4 completed, 2 not yet recruiting, 1 terminated, 1 unknown. 3 Phase 3, 2 Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow SAR: new trials by email Literature Review of SAR trials Research Report on SAR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR) Stapokibart - SAR | Not yet recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 400 | 2026-03-01 | 2026-03-09 | |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis PG-011 nasal spray 0.6%(twice daily), Placebo - Seasonal Allergic Rhinitis, SAR | Phase 3 | Not yet recruiting | Prime Gene Therapeutics Co., Ltd. | 600 | 2025-09-15 | 2025-08-28 |
| (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC CBDRA60 supplement, Placebo - COVID-19, SAR | Not applicable | Unknown | Anewsha Therapeutics Inc. | 60 | 2022-07-01 | 2022-02-22 |
| CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas CCT301-38 - SAR | Phase 1 | Terminated | Shanghai PerHum Therapeutics Co., Ltd. | 9 | 2021-12-30 | 2024-10-28 |
| Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients allogeneic mesenchymal stem cell, Placebo - Covid19, Corona Virus Infection | Phase 1 | Completed | Ina-Respond | 9 | 2020-11-14 | 2021-01-27 |
| Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. Vitamin D, PLACEBO - SAR, SARS Pneumonia | Phase 3 | Completed | Bioaraba Health Research Institute | 108 | 2020-11-09 | 2022-07-15 |
| Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies BDP HFA, Placebo nasal aerosol - Seasonal Allergic Rhinitis, SAR | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 715 | 2011-03-01 | 2015-02-20 |
| Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) Cetirizine, Loratadine, Placebo - Allergic Rhinitis, Hay Fever | Phase 4 | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | 683 | 2001-03-01 | 2017-04-20 |
Rhinitis, Allergic, Seasonal (3) · COVID-19 (2) · Communicable Diseases (1) · Coronavirus Infections (1) · Hypersensitivity (1) · Rhinitis, Allergic (1) · Sarcoma (1)
Respiratory Tract Diseases (5) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Nose Diseases (3) · Otorhinolaryngologic Diseases (3) · Respiratory Hypersensitivity (3) · Rhinitis (3) · Coronaviridae Infections (2) · Hypersensitivity (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2)
Beclomethasone (1) · Cetirizine (1) · Loratadine (1) · Nasal Sprays (1) · Vitamin D (1) · alpha-ketoisovalerate dehydrogenase phosphatase (1) · apaflurane (1)
Anewsha Therapeutics Inc. (1) · Bioaraba Health Research Institute (1) · Chengdu Kangnuoxing Biopharma,Inc. (1) · Ina-Respond (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · Prime Gene Therapeutics Co., Ltd. (1) · Shanghai PerHum Therapeutics Co., Ltd. (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
China (3) · United States (2) · Indonesia (1) · Spain (1)
Dial Hewlett, MD (1) · Dr. Muhammad Karyana, MPH (1) · Eleni Stylianou, PHD (1) · Luo Zhang, Professor (1)